Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens.
Vaccination of cattle against bovine tuberculosis could be an important strategy for the control of disease either where there is a wildlife reservoir of Mycobacterium bovis infection or in developing countries where it is not economically feasible to implement a 'test and slaughter' control program. Advances in the understanding of protective immune responses to M. bovis infection in cattle and the advent of new molecular biological techniques, coupled with the sequencing of the M. bovis genome have provided opportunities for the rational development of improved tuberculosis vaccines. A number of new tuberculosis vaccines including attenuated M. bovis strains, killed mycobacteria, protein and DNA vaccines are under development and many are being assessed in cattle. Recent results have revealed several promising vaccine candidates and vaccination strategies. Ways of distinguishing between vaccinated and infected cattle are becoming available and the possibility of new approaches to the eradication of tuberculosis from domestic livestock is discussed. Similarities between the mechanisms of protective immunity against M. bovis and against other intracellular parasites continue to be found and discoveries from vaccine studies on bovine tuberculosis may provide helpful insights into requirements for vaccines against other intracellular pathogens.
Buddle
Bryce M
BM
AgResearch, Wallaceville Animal Research Centre, P.O. Box 40063, Upper Hutt, New Zealand. bryce.buddle@agresearch.co.nz
Pollock
John M
JM
Skinner
Margot A
MA
Wedlock
D Neil
DN
D000818:Animals; D000831:Animals, Newborn / Q000276:immunology; D000835:Animals, Wild / Q000276:immunology; D001500:BCG Vaccine / Q000276:immunology / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000276:immunology; D002417:Cattle; D003906:Developing Countries; D016680:Genome, Bacterial; D007111:Immunity, Cellular / Q000276:immunology; D009163:Mycobacterium bovis / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D032581:Tuberculosis Vaccines / Q000276:immunology / Q000627:therapeutic use*; D014380:Tuberculosis, Bovine / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D014611:Vaccination / Q000379:methods; D014613:Vaccines, Attenuated / Q000276:immunology / Q000627:therapeutic use; D019444:Vaccines, DNA / Q000276:immunology / Q000627:therapeutic use; D014774:Virulence
D001500:BCG Vaccine; D001426:Bacterial Proteins; D032581:Tuberculosis Vaccines; D014613:Vaccines, Attenuated; D019444:Vaccines, DNA